AmerisourceBergen 2013 Annual Report Download

Download and view the complete annual report

Please find the complete 2013 AmerisourceBergen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 24

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24

2 0 1 3 S u m m a r y A n n u a l R e p o r t
Delivering
Growth

Table of contents

  • Page 1
    2013 Summary Annual Report Delivering Growth

  • Page 2
    ..., Steven H. Collis, President and Chief Executive Officer 4 Global Pharmaceutical Sourcing and Distribution 6 Pharmacy Solutions 8 Provider Solutions 10 Manufacturer Solutions 12 Corporate and Social Responsibility 14 Management Team 15 Letter to Stockholders, Richard C. Gozon, Chairman of the Board...

  • Page 3
    .... Our increasing focus on global sourcing and distribution services that improve product access, increase supply chain efficiency, and enhance patient care, position us well to seize these opportunities for growth. Fiscal 2013- A Transformational Year AmerisourceBergen delivered solid financial...

  • Page 4
    ...implementation of our enterprise resource planning system, thereby enhancing our information technology platform, and onboarded several billion dollars of new business from our largest pharmacy benefit manager customer. Importantly, AmerisourceBergen Drug Corporation's other customer categories also...

  • Page 5
    ... to our health systems customers. AmerisourceBergen Specialty Group revenues in fiscal 2013 increased 8%, as strong performance in Besse medical, ASD, and ICS offset a decline in the Oncology Supply business, which was impacted by changes in government reimbursement rates for drugs administered by...

  • Page 6
    ... global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement...

  • Page 7
    ...pharmaceutical Distribution segment includes the operations of AmerisourceBergen Drug Corporation ("ABDC") and AmerisourceBergen Specialty Group ("ABSG"). Other consists of our manufacturer services businesses, AmerisourceBergen Consulting Services (ABCS), and World Courier. Select audited financial...

  • Page 8
    ... operating efficiency. AmerisourceBergen's extensive supply chain services enhance market and patient access, facilitate financial management and mitigate financial risk, and capture and manage substantial inventory information. Our pharmacy solutions help dispensers reduce costs, increase patient...

  • Page 9
    ... health systems customers cover three key areas: quality care solutions, market growth solutions and cost control solutions. Whether through helping hospitals manage an expansion in oncology care or through helping support a health system's medication policies, processes and patient-level medication...

  • Page 10
    ... world. ImS health forecasts that specialty pharmaceutical sales will increase by 38% between 2013 and 2017 on a global basis. The current research and development pipeline for new products is heavily weighted towards specialty products, particularly in oncology, as reported by the Center for Supply...

  • Page 11
    ... care. AmerisourceBergen Specialty Group plays a central and vital role in the specialty market. We are the market leader in the specialty distribution of oncology products, blood plasma products and biotech injectibles. In addition, we provide technologies and specialty pharmacy services that help...

  • Page 12
    ... our manufacturer services is our global sourcing and distribution expertise. In addition, our marketleading specialty physician networks and world-class patient support services enable us to provide comprehensive solutions designed to drive optimal product access and ultimately help improve patient...

  • Page 13
    ... its platform to help expand our other manufacturer services businesses in international markets. These efforts will be further enhanced through our efforts with Walgreens and Alliance Boots to collaboratively drive global supply chain efficiency, and explore opportunities to drive meaningful...

  • Page 14
    ... off, the opportunity to participate in the Company's 401(k) plan, educational opportunities, tuition reimbursement and other benefits. Corporate Governance AmerisourceBergen routinely reviews its corporate governance principles, the Board Committee charters, codes of conduct and other governance...

  • Page 15
    ...on an annual basis. The conduct we require of our directors, officers and employees in their interactions with government officials is reflected in the Company's Code of Ethics and Business Conduct. of decommissioned hardware and technology in an environmentally responsible manner, and we work with...

  • Page 16
    ... and Chief Financial Officer John G. Chou Executive Vice President and General Counsel David W. Neu Senior Vice President and President, AmerisourceBergen Drug Corporation Peyton R. Howell Senior Vice President and President, Global Sourcing and Manufacturer Relations James D. Frary Senior Vice...

  • Page 17
    ... Officer, Constellation Energy Resources Michael J. Long 1,2*,5 Chairman, President and Chief Executive Officer, Arrow Electronics, Inc. Henry W. McGee 1,4 Former President, HBO Home Entertainment Senior Lecturer, Harvard Business School COMMITTEES OF THE BOARD 1 Audit and Corporate Responsibility...

  • Page 18
    ... data) Fiscal year ended September 30, Revenue Cost of goods sold Gross profit Operating expenses: Distribution, selling and administrative Depreciation Amortization Warrants Employee severance, litigation and other Intangible asset impairments Operating income Other loss (income) Interest expense...

  • Page 19
    ...allowances for returns and doubtful accounts: 2013 - $358,161; 2012 - $338,245 Merchandise inventories Prepaid... held for sale Total current liabilities Long-term debt Other liabilities Stockholders' equity...the Company's Annual Report on Form 10-K as filed with the SEC for the Fiscal Year Ended September...

  • Page 20
    ... 30, 2013 2012 2011 Operating Activities Net income Loss (income) from discontinued operations Income from continuing operations Adjustments to reconcile income from continuing operations to net cash provided by operating activities: Depreciation, including amounts charged to cost of goods sold...

  • Page 21
    Summary Segment Information (dollars in thousands) (unaudited) Fiscal year ended September 30, 2013 2012 Revenue Pharmaceutical Distribution Other Intersegment eliminations Revenue $86,063,531 2,087,968 (192,332) $87,959,167 $76,689,550 1,575,738 (184,482) $78,080,806 Operating Income ...

  • Page 22
    ... of certain qui tam litigation expense was not tax deductible. 20 See notes to consolidated financial statements in the Company's Annual Report on Form 10-K as filed with the SEC for the Fiscal Year Ended September 30, 2013. In addition, see information provided in the Company's Form 8-K filed...

  • Page 23
    ... as our Annual Report on Form 10-K, and quarterly reports on Form 10-Q, and other reports and filings, such as the Company's Code of Ethics and Business Conduct, may be obtained from the Company website at www.amerisourcebergen.com, or by calling the Company's Investor Relations Department at 610...

  • Page 24
    ... enhance patient care. With services ranging from drug distribution and niche premium logistics to reimbursement and pharmaceutical consulting services, AmerisourceBergen delivers innovative programs and solutions across the pharmaceutical supply channel. With over $100 billion in annualized revenue...